News | Neuro Imaging | September 15, 2015

MRI Improves Diagnosis of Microbleeding after Brain Injury in Military Personnel

Researchers determine imaging closer to time of injury improves detection of microhemorrhages

MRI, improves diagnosis, microbleeding, traumatic brain injury, TBI, military, Radiology, microhemorrhages

September 15, 2015 — Imaging patients soon after a traumatic brain injury (TBI) can lead to more accurate detection of cerebral microhemorrhages, or microbleeding on the brain, according to a study of military service members. Results were published online in the journal Radiology.

Cerebral microhemorrhages occur as a direct result of TBI and can lead to severe secondary injuries such as brain swelling or stroke. The ability to monitor the evolution of microhemorrhages could provide important information regarding disease progression or recovery.

According to the Centers for Disease Control and Prevention’s (CDC) National Center for Injury and Prevention Control, about 1.7 million people in the United States sustain TBI each year. Furthermore, the Institute of Medicine reports that 20 to 23 percent of military service members deployed to Afghanistan and Iraq have sustained TBI while serving.

“TBI is a large problem for our military service members and their families,” said Gerard Riedy, M.D., Ph.D., chief of neuroimaging at the National Intrepid Center of Excellence at the Walter Reed National Military Medical Center in Bethesda, Maryland. “We found that many of those who have served and suffered this type of injury were not imaged until many, many months after injury occurred, thus resulting in lower rates of cerebral microhemorrhage detection which delays treatment.”

For the study, Riedy and colleagues used susceptibility-weighted imaging—a magnetic resonance imaging (MRI) technique that provides improved visibility of blood and is highly sensitive to hemorrhage—to evaluate 603 military service members with TBI. The median time from point of injury to imaging was 856 days. Of the 603 military service members who participated in the study, 7 percent were found to have at least one occurrence of cerebral microhemorrhage.

The patients were divided into four groups based on time since the injury occurred, ranging from less than three months to over a year. The results found that those who were imaged more than a year after the injury had a much lower occurrence of cerebral microhemorrhages than those who were scanned 12 months or fewer after TBI.

Cerebral microhemorrhage was identified in 24 percent of military personnel who were imaged within three months post-injury, compared to 5.2 percent of the patients who were imaged over a year later. The researchers attribute this to changes in iron deposits in the brain as time goes on, making it more difficult to detect microbleeding.

“Early characterization of cerebral microhemorrhages may help to explain clinical symptoms of acute TBI and identify the severity of brain damage,” Riedy said. “We believe that having access to MRI in the field would facilitate early detection of TBI, thus providing timely treatment.”

The study also supports previous claims that using susceptibility-weighted imaging to evaluate brain injury patients may be more effective than conventional MRI. In this study’s capacity, using susceptibility-weighted imaging resulted in detecting significantly more microhemorrhages due to a higher spatial resolution and signal, with 77 percent of cerebral microhemorrhages appearing more evident through susceptibility-weighted imaging when compared to conventional MRI.

For more information: www.nicoe.capmed.mil

Related Content

Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI) | September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
Siemens Healthineers to Showcase Magentom Vida MRI at RSNA 2017
Technology | Magnetic Resonance Imaging (MRI) | September 18, 2017
September 18, 2017 — Siemens Healthineers announced it will display the new Magnetom Vida 3T...
Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents
News | Contrast Media | September 12, 2017
The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC) voted overwhelmingly...
News | Imaging | September 11, 2017
September 11, 2017 — Innovatus Imaging Corp., a newly created holding company formed by private equity firm Resilienc
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Sponsored Content | Videos | Radiation Therapy | September 08, 2017
The new Visicoil MR is a helically-wound, flexible linear fiducial marker.
Overlay Init